Rohan Dhamdhere

Rohan Dhamdhere

Auto-generated profile, based on publicly available information

Rohan Dhamdhere

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University , Health Sciences Research Building II, 1750 Haygood Drive, Suite N647, Atlanta, GA 30322

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2020 in IEEE Geoscience and Remote Sensing Letters
Verified
Journal Article
Closed access
OLORNL Lunga
ORNL Lunga
RDRohan Dhamdhere
Rohan Dhamdhere
SWSarah Walters
Sarah Walters
LBLauryn Bragg
Lauryn Bragg
NMNikhil Makkar
Nikhil Makkar
MUMarie Urban
Marie Urban
Understanding how people occupy open spaces is important for research in support of population modeling, policy, national security, emergency response, and sustainability. For the past decade, there has been an increase in research toward capturing and reporting population dynamics and patterns of life at the building level and in some open public spaces such as cemeteries and parks. This is done through observation models developed from local sociocultural information acquired at various spatiotemporal scales to inform night, day, and episodic population occupancy estimates (people/1000 sq ft). Sociocultural information for cemeteries and parks is scarcely available and often collected manually. The process is not only marred by inconsistencies but is laborious and time consuming. In this study, we leverage convolutional neural networks (CNNs) and satellite imagery to derive grave site counts as proxy variables to support scalable and accurate sociocultural data required in a population observation model. Through a hybrid workflow (weak localization plus regression model), we characterize a large scale automation process to counting of grave sites. We evaluate and demonstrate the efficacy of proposed workflow using out-of-data set large satellite imagery and establish its broader impact on cemetery observation models.

26 October 2022 in EBioMedicine
Verified
Journal Article
Open access
GMGOURAV MODANWAL
GOURAV MODANWAL
SASadeer Al-Kindi
Sadeer Al-Kindi
JWJonathan Walker
Jonathan Walker
RDRohan Dhamdhere
Rohan Dhamdhere
LYLei Yuan
Lei Yuan
AMAnant Madabhushi
Anant Madabhushi
Hepatic steatosis (HS) identified on CT may provide an integrated cardiometabolic and COVID-19 risk assessment. This study presents a deep-learning-based hepatic fat assessment (DeHFt) pipeline for (a) more standardised measurements and (b) investigating the association between HS (liver-to-spleen attenuation ratio <1 in CT) and COVID-19 infections severity, wherein severity is defined as requiring invasive mechanical ventilation, extracorporeal membrane oxygenation, death. DeHFt comprises two steps. First, a deep-learning-based segmentation model (3D residual-UNet) is trained (N = 80) to segment the liver and spleen. Second, CT attenuation is estimated using slice-based and volumetric-based methods. DeHFt-based mean liver and liver-to-spleen attenuation are compared with an expert's ROI-based measurements. We further obtained the liver-to-spleen attenuation ratio in a large multi-site cohort of patients with COVID-19 infections (D1, N = 805; D2, N = 1917; D3, N = 169) using the DeHFt pipeline and investigated the association between HS and COVID-19 infections severity. The DeHFt pipeline achieved a dice coefficient of 0.95, 95% CI [0.93–0.96] on the independent validation cohort (N = 49). The automated slice-based and volumetric-based liver and liver-to-spleen attenuation estimations strongly correlated with expert's measurement. In the COVID-19 cohorts, severe infections had a higher proportion of patients with HS than non-severe infections (pooled OR = 1.50, 95% CI [1.20–1.88], P < .001). The DeHFt pipeline enabled accurate segmentation of liver and spleen on non-contrast CTs and automated estimation of liver and liver-to-spleen attenuation ratio. In three cohorts of patients with COVID-19 infections (N = 2891), HS was associated with disease severity. Pending validation, DeHFt provides an automated CT-based metabolic risk assessment. For a full list of funding bodies, please see the Acknowledgements.

9 July 2026 in European Heart Journal
Verified
Journal Article
Open access
MLMendel Lebowitz
Mendel Lebowitz
GMGOURAV MODANWAL
GOURAV MODANWAL
ASAmritpal Singh
Amritpal Singh
RDRohan Dhamdhere
Rohan Dhamdhere
SDSaumya Diwan
Saumya Diwan
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
Background and Aims: Chronological age is central to cardiovascular disease (CVD) risk estimation but poorly reflects interindividual heterogeneity in cardiovascular aging. This study developed a peri-aortic adipose tissue (PAAT) radiomic cardiovascular age (CV-Age) biomarker from routine chest CT and tested whether the PAAT age gap (ΔAge = CV-Age − chronological age) stratifies major adverse cardiovascular events (MACE) and improves risk classification. Methods: Four chest CT cohorts with different protocols were utilized to train (n = 4451) and externally validate (n = 44 214) a CV-Age model. Associations between ΔAge decile groups (resilient ≤10th; accelerated ≥90th) and incident 5-point MACE (myocardial infarction, stroke, revascularization, heart failure, and death) were assessed using survival models. Clinical utility was evaluated by substituting CV-Age for chronological age in PREVENT to quantify risk reclassification. Results: A 31-feature radiomic signature capturing PAAT volume, attenuation, and texture heterogeneity predicted age with good accuracy (training MAE 2.2 years; primary external validation MAE 2.7 years). In a separate higher-risk cohort, predictions showed a positive ΔAge (median +5.4 years), reflecting elevated baseline cardiovascular burden. ΔAge-stratified event-free survival differed across groups (log-rank P < .001); compared with normative agers, accelerated agers had higher MACE risk (HR 1.51, 95% CI 1.37–1.66), and resilient agers had lower risk (HR 0.70, 0.63–0.77). Substituting CV-Age into PREVENT improved risk reclassification (categorical NRI +0.03, P < .01, continuous NRI +0.04, P < .05). Conclusions: Radiomic profiling of PAAT on routine chest CT yields a scalable imaging biomarker of cardiovascular aging. CV-Age can help improve identification of higher-risk individuals missed by age-driven risk estimation, supporting its role as a risk-enrichment tool.

18 August 2025 in Kidney360
Verified
Journal Article
Open access
RDRohan Dhamdhere
Rohan Dhamdhere
GMGOURAV MODANWAL
GOURAV MODANWAL
PMPushkar Mutha
Pushkar Mutha
SMSebastian Medina
Sebastian Medina
SASruthi Arepalli
Sruthi Arepalli
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
Key Points: Retinal imaging reveals microvascular changes associated with cardiovascular (CV) risk in patients with CKD. A retinal vascular model improves risk stratification compared with established clinical risk scores for CV events. Integrating retinal analysis with clinical markers enhances CV risk assessment in patients with CKD. Background: Patients with CKD face an elevated but variable risk of cardiovascular (CV) disease. Retinal imaging in CKD provides a noninvasive opportunity for CV risk stratification through microvascular analysis. The objective of this study was to evaluate retinal vascular features extracted via computer vision and machine learning approaches for CV risk and their added value over established risk calculators in patients with CKD. Methods: Retinal scans from 1333 participants of the multicenter clinical observational study Chronic Renal Insufficiency Cohort (NCT00304148) were analyzed. A deep learning pipeline segmented vessels and then identified arterioles and venules from them. Segmented vessel, arteriole, and venule masks were used to extract 384 vascular features. An elastic-net model—Cardiovascular Assessment through Retinal Evaluation in CKD (CARE-CKD; M CARE )—was trained, using the top eight features, on 567 participants (101 major adverse cardiovascular events [MACE]: composite of myocardial infarction, stroke, heart failure) and validated on 244 participants (44 MACE). A nomogram integrating M CARE with clinical markers (age, sex, blood pressure, smoking, eGFR, albuminuria, cholesterol, body mass index, and diabetes status) was developed. Results: M CARE demonstrated strong prognostic performance for predicting MACE, (C-index=0.70, hazard ratio [HR] =3.95, above versus below median; 95% confidence interval [CI], 2.36 to 6.63; P <0.001), outperforming the Framingham Risk Score (C-index=0.66; HR=1.06; Likelihood Ratio Test [LRT] P < 0.01) and Predicting Risk of cardiovascular disease EVENTs (PREVENT; C-index=0.65; HR=1.84; LRT P < 0.001) calculators. M CARE improved risk stratification within Framingham Risk Score–based high-risk (HR=3.73; P < 0.001) and Predicting Risk of cardiovascular disease EVENT–based high-risk (HR=4.73; P < 0.001) categories. Nomogram enhanced risk stratification (C-index=0.77; HR=3.81; P <0.0001) compared with clinical markers (LRT P < 0.01). Conclusions: CARE-CKD provides a novel, opportunistic approach to CV risk assessment in CKD, outperforming the established risk calculators and refining stratification within high-risk categories. By enabling earlier identification, close monitoring, and targeted management of high-risk patients, CARE-CKD addresses gaps left by traditional calculators, maximizing the benefits of emerging therapies and potentially improving long-term outcomes.

31 March 2026 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SBSatvika Bharadwaj
Satvika Bharadwaj
GCGermán Corredor
Germán Corredor
HAHilmi Al-Shakhshir
Hilmi Al-Shakhshir
SMSebastian Medina
Sebastian Medina
SASahar N. Almahfouz
Sahar N. Almahfouz
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
Purpose: Trastuzumab-based chemotherapy has improved outcomes in human epidermal growth factor receptor 2 (HER2)–positive breast cancer, but treatment benefit varies among patients. Predictive signatures are needed to identify patients most likely to respond to these therapies. Experimental Design: We developed Density and Spatial architecture of Tumor-Infiltrating Lymphocytes (DeSTIL), a computational signature derived from hematoxylin and eosin slides. The signature captures spatial organization of immune cells and interactions with nonimmune cells. DeSTIL was trained on HER2+ breast cancer slides from The Cancer Genome Atlas (n = 250) and validated in a phase III National Surgical Adjuvant Breast and Bowel Project (NSABP) B-41 randomized clinical trial (n = 221), which compared chemotherapy plus trastuzumab, lapatinib, or combination. The DeSTIL scores were dichotomized into positive and negative groups, and event-free survival (EFS) was assessed using Cox proportional hazards with interaction terms. Results: In NSABP B-41, DeSTIL-positive patients (n = 61) showed significantly improved event-free survival (EFS) with trastuzumab compared with the combination arm [hazard ratio (HR) = 0.09; 95% confidence interval (CI) = 0.01–0.77; P = 0.006] and a significant signature–treatment interaction (P = 0.024). No EFS difference was observed in DeSTIL-negative patients (n = 160). Gene expression analysis supported the image-derived signature stratifying DeSTIL-positive and DeSTIL-negative tumors. In an exploratory pathologic complete response analysis, a classifier trained on University Hospitals Cleveland slides achieved AUCs of 0.70 in the training cohort and 0.63 in the trastuzumab arm of the NSABP B-41 validation cohort. Conclusions: DeSTIL identifies a subset of HER2+ patients who derive greater benefit from trastuzumab. These findings support the potential of computationally derived immune architecture to inform selection of standard HER2-targeted therapies.

15 June 2026
Verified
Other
Open access
SBSatvika Bharadwaj
Satvika Bharadwaj
GCGermán Corredor
Germán Corredor
HAHilmi Al-Shakhshir
Hilmi Al-Shakhshir
SMSebastian Medina
Sebastian Medina
SASahar N. Almahfouz
Sahar N. Almahfouz
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
Supplementary Figures S1-S11 and Supplementary Tables S1-S4